Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic

TY - JOUR

T1 - Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic

AU - Price, Kyla N.

AU - Thiede, Rebecca

AU - Shi, Vivian Y.

AU - Curiel-Lewandrowski, Clara

N1 - Funding Information: Disclosure: Dr Shi is a stock shareholder of Learn Health and has served as an advisory board member and/or investigator and/or has received research funding from Sanofi Genzyme, Regeneron, AbbVie, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Menlo Therapeutics, Burt's Bees, GpSkin, Altus Labs, and Skin Actives Scientific; there were no incentives or transactions, financial or otherwise, relevant to this manuscript. Dr Curiel-Lewandrowski has served as an advisory board member and/or investigator and/or has received research funding from Amgen, Bristol-Myers Squibb, Helsinn, and Novartis; there were no incentives or transactions, financial or otherwise, relevant to this manuscript. Ms Price and Dr Thiede have no conflicts of interest to declare. Funding sources: None.

PY - 2020/6

Y1 - 2020/6

UR - https://www.scopus.com/pages/publications/85083849478

UR - https://www.scopus.com/pages/publications/85083849478#tab=citedBy

U2 - 10.1016/j.jaad.2020.03.089

DO - 10.1016/j.jaad.2020.03.089

M3 - Letter

C2 - 32277972

AN - SCOPUS:85083849478

SN - 0190-9622

VL - 82

SP - e207-e209

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -